cyclosporine and Stevens-Johnson Syndrome

cyclosporine has been researched along with Stevens-Johnson Syndrome in 84 studies

Research

Studies (84)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (7.14)	18.2507
2000's	13 (15.48)	29.6817
2010's	42 (50.00)	24.3611
2020's	23 (27.38)	2.80

Authors

Authors	Studies
Al Abri, AM; Al Rajaibi, R; Al Rumhi, T	1
Are, A; Frantz, R; Huang, S; Motaparthi, K	1
Atti, C; Hoyer, D; Nuding, S; Schott, A; Sedding, DG; Vogt, A	1
Borrelli, MR; Branski, LK; Duscher, D; Grieb, G; Houschyar, KS; Lehnhardt, M; Maan, ZN; Nietzschmann, I; Ooms, M; Pförringer, D; Philipp-Dormston, WG; Puladi, B; Rein, S; Reumuth, G; Schmitt, L; Schulz, T; Siemers, F; Tapking, C; Wallner, C; Yazdi, AS	1
Beecker, J; Jacobsen, A; Langley, A; Mutter, E; Olabi, B; Pardo Pardo, J; Parker, R; Ramsay, T; Saavedra, A; Shelley, A; Stewart, F; Worley, B	1
Chen, CB; Chung, WH; Wang, CW	1
Chen, A; Chen, S; Hu, L; Ma, C; Pan, Y; Wei, B; Yu, R	1
Bourke, J; Cunneen, T; Frederiks, AJ; Kumarasinghe, SP; Raby, E; Ricciardo, B; Rowe, S; Wood, F	1
Fischer, G; Fong, G; Kherlopian, A; Mewton, E	1
Ameri, M; Barau, C; Brüggen, MC; Contassot, E; de Prost, N; French, LE; Ingen-Housz-Oro, S; Lalevée, S; Meier-Schiesser, B; Mitamura, Y; Nägeli, M; Navarini, AA; Schmidt, V; Traidl, S; Ziadlou, R	1
Phillips, M; Singh, N	1
Benaïm, D; Béral, L; Bernier, C; Bodemer, C; Brémond-Gignac, D; Burillon, C; Cassagne, M; Cordel, N; Couret, C; Daien, V; Delcampe, A; Dereure, O; Gabison, E; Gueudry, J; Ingen-Housz-Oro, S; Kuoch, MA; Milpied, B; Muraine, M; Robert, M; Royer, G; Saunier, V; Servant, M; Tauber, M; Tétart, F; Thorel, D; Touboul, D; Vabres, B; Vasseur, R; Welfringer-Morin, A	1
Ashinoff, R; Gordon, M; Meledathu, S; Thornton, M	1
Cai, L; Liu, XY; Zhang, JZ; Zhang, S; Zhou, C	1
Nakamura, R; Saito, Y	1
Chodosh, J; Hall, LN; Rashad, R; Saeed, HN; Shanbhag, SS	1
Charlton, OA; Cooper, A; Harris, V; Jackson, C; Mewton, E; Phan, K	1
Wildermuth, A	1
Botella-Estrada, R; Briz-Redón, Á; Torres-Navarro, I	1
Bozca, BC; Irican, CM; Karakaş, AA	1
de Lucas-Laguna, R; Feito-Rodríguez, M; Nieto-Rodríguez, D; Quintana-Castanedo, L; Rodríguez-Álvarez, D	1
Deshmukh, R; Dua, HS; Elsahn, A; Mohammed, I; Said, DG; Ting, DSJ	1
Dash, S; Mishra, S; Sirka, CS; Viswan, P	1
Brezinová, E; Brüggen, MC; Bygum, A; Chua, SL; de Prost, N; Didona, B; Divani-Patel, S; French, L; Ingen-Housz-Oro, S; Karpaviciute, V; Kridin, K; Kucinskiene, V; Lorentzen, T; Milpied, B; Nagel, JL; Nägeli, MC; Oppel, E; Oschmann, A; Ranki, A; Salavastru, C; Tétart, F; Tiplica, GS; Valiukeviciene, S; Vorobyev, A; Walsh, S	1
Knaus, J; Mockenhaupt, M; Motschall, E; Schumacher, M; Sekula, P; Venhoff, M; Zimmermann, S	1
Kanti Das, N; Kumar, P	1
Cohen, PR; Schneider, JA	1
Bellón, T; Cachafeiro, L; de Abajo, FJ; González, O; González-Herrada, C; González-Ramos, J; Lerma, V; Lorente, JA; Ramírez, E; Rodríguez-Martín, S; Rodríguez-Miguel, A; Roustan, G	1
Kinoshita, Y; Saeki, H	1
Bach, DQ; Badri, O; Gracey, LE; Ho, AW; Kroshinsky, D; Liu, KJ; Raff, AB; Ratushny, V; Schalock, P; St John, J; Sugai, DY	1
Guillaume, JC; Mockenhaupt, M; Revuz, J; Roujeau, JC	1
Harr, T; Lerch, M; Mainetti, C; Terziroli Beretta-Piccoli, B	1
Chosidow, O; Colin, A; de Prost, N; Duong, TA; Fardet, L; Gaudin, O; Hotz, C; Hua, C; Ingen-Housz-Oro, S; Le Cleach, L; Lebrun-Vignes, B; Poizeau, F; Sbidian, E; Wolkenstein, P; Zehou, O	1
Callen, JP; Conner, CD; McKenzie, E; Owen, CE	1
Micheletti, RG; Mostaghimi, A; Noe, MH; Rosenbach, M; Shinkai, K	1
Dutz, J; Evans, M; Kirchhof, M; Miliszewski, M; Papp, A; Sikora, S; Song, D	1
Baran, M; Brychta, P; Bukovčan, P; Cvanová, M; Eimer, L; Grossová, I; Hanslianová, M; Holoubek, J; Jandová, M; Klein, L; Koller, J; Košťál, M; Lengyel, P; Lipový, B; Zajíček, R	1
Gilbert, M; Scherrer, LA	1
Kaushik, A; Kumaran, MS; Mehta, S; Singh, P; Vinay, K	1
Chen, ST; Kroshinsky, D; Shah, R	1
Fustà-Novell, X; Iranzo, P; Morgado-sCarrasco, D	1
Kaushik, A; Kumaran, MS; Parsad, D; Vinay, K	1
Castelain, F; Humbert, P	1
Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB	1
Abela, C; Bunker, CB; De Leo, A; de Sica Chapman, A; Hartmann, CE; Jawad, M; Leon-Villapalos, J; Shah, H; Williams, GJ	1
Dutz, JP; Kirchhof, MG; Miliszewski, MA; Papp, A; Sikora, S	1
Dotor, A; González-Herrada, C; Lapresta, A	1
Christensen, LC; Cochran, AL; Collins Brummer, G; Curtis, JA; Hull, CM; Paine, AR; Petersen, MJ; Summers, EM	1
Boull, CL; Hook, KP; Hylwa, SA; Sajic, D; Tolar, J; Wagner, JE	1
Shokeen, D	1
Gregory, DG	1
Ardern-Jones, MR; Brown, D; Bunker, CB; Creamer, D; Dart, JK; Dziewulski, P; Exton, LS; Lee, HY; Martin, RV; Mohd Mustapa, MF; Philippidou, M; Setterfield, J; Shah, M; Smith, CH; Vercueil, A; Walsh, SA; Watson, KM; Williams, G; Williams, P; Wong, GA	1
Bromley, J; Schulze, R; Thacker, S; Thomas, L; Weng, M	1
Fook-Chong, S; Koh, HY; Lee, HY; Pang, SM; Thirumoorthy, T	1
Cooper, A; Harris, V; Jackson, C	1
Cassel, KP; Eckersley, D; Moscati, RM; Singh, PA	1
Koh, MJ; Tay, YK	1
Lateef, A; Lau, TC; Tan, KB	1
Broadfoot, AJ; Fernando, SL	1
Lam, PT; Tam, PM; Young, AL	1
Balasubramaniam, P; Lewis, H; Lim, R; Mann, C; Marsden, JR; Moiemen, N; Papini, R; Rajaratnam, R; Shah, F; Taibjee, SM	1
Bagot, M; Brochard, L; Maître, B; Ortonne, N; Revuz, J; Roujeau, JC; Valeyrie-Allanore, L; Wolkenstein, P	1
Carmona, AF; Gómez, AG; Martínez, JL; Pareja, JC; Peña, LO; Redondo, AD	1
Gilson, R; Henning, JS; Ladd, D; Reese, D; Rockers, K	1
Fernando, SL	1
Karnchanachetanee, C; Kasemson, S; Prabhasawat, P; Tesavibul, N	1
Delvenne, P; Mazzucchelli, G; Meuwis, MA; Paquet, P; Piérard, GE	1
Bandara, D; Hashim, N; Ilchyshyn, A; Tan, E	1
Chave, TA; Hall, AP; Hutchinson, PE; Mortimer, NJ; Sladden, MJ	1
Damas, P; Jacob, E; Paquet, P; Piérard, G; Pirson, J	1
Akimoto, M; Aoki, N; Arima, N; Fujiwara, H; Hamada, H; Inoue, H; Kaieda, T; Matsushita, K; Ozaki, A; Satomura, A; Suruga, Y; Tei, C	1
Avilés Izquierdo, J; Chavarria Mur, E; García Sánchez, I; Gilsanz Fernández, C; Molina Sánchez-Cabezudo, F; Vera López, E	1
Aihara, M; Aihara, Y; Ito, R; Ito, S; Yokota, S	1
Paulo, JD; Pineda-Tamayo, R; Rojas-Villarraga, A; Zapata, LF; Zapata-Castellanos, AL	1
Dalziel, KL; Patel, S; Reed, R; Zaki, I	1
Havill, J; Jarrett, P; Pullon, H; Rademaker, M	1
Arévalo, JM; Lorente, JA	1
Paquet, P; Piérard, GE	1
Adami, JZ; Mallia, C; Mizzi, A; Pace, J	1
Arévalo, JM; González-Herrada, C; Jiménez-Reyes, J; Lorente, JA	1
Balda, BR; Konstantinow, A; Mühlbauer, W; Ring, J	1
Chojnowski, K; Góra-Tybor, J; Robak, E; Robak, T; Strzelecka, B; Sysa-Jedrzejowska, A; Waszczykowska, E	1
de la Mata, J; Fernández-Espartero, MC; Rodríguez, M; Satué, JA	1
Hewitt, J; Ormerod, AD	1

Reviews

32 review(s) available for cyclosporine and Stevens-Johnson Syndrome

Article	Year
Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review. Sultan Qaboos University medical journal, 2021, Volume: 21, Issue:3 Topics: Adult; Carbamazepine; Cyclosporine; Female; Humans; Oman; Stevens-Johnson Syndrome	2021
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. Medicina (Kaunas, Lithuania), 2021, Aug-28, Volume: 57, Issue:9 Topics: Adrenal Cortex Hormones; Cyclosporine; Humans; Immunoglobulins, Intravenous; Skin; Stevens-Johnson Syndrome	2021
Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. Journal of wound care, 2021, Dec-02, Volume: 30, Issue:12 Topics: Cohort Studies; Cyclosporine; Humans; Immunoglobulins, Intravenous; Retrospective Studies; Skin; Stevens-Johnson Syndrome	2021
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. The Cochrane database of systematic reviews, 2022, 03-11, Volume: 3 Topics: Acetylcysteine; Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Child; Cyclosporine; Etanercept; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Observational Studies as Topic; Stevens-Johnson Syndrome; Thalidomide; Tumor Necrosis Factor-alpha	2022
Toxic epidermal necrolysis in adult patients: Experience from the West Australian Collaboration. The Australasian journal of dermatology, 2022, Volume: 63, Issue:4 Topics: Adult; Australia; Burns; Cyclosporine; Humans; Retrospective Studies; Stevens-Johnson Syndrome	2022
Toxic Epidermal Necrolysis: A Review of Past and Present Therapeutic Approaches Skin therapy letter, 2022, Volume: 27, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Stevens-Johnson Syndrome	2022
Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management. Orphanet journal of rare diseases, 2023, 03-11, Volume: 18, Issue:1 Topics: Adrenal Cortex Hormones; Cyclosporine; Disease Progression; Humans; Lubricant Eye Drops; Stevens-Johnson Syndrome	2023
Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review. Journal of drugs in dermatology : JDD, 2023, Nov-01, Volume: 22, Issue:11 Topics: Adrenal Cortex Hormones; Cyclosporine; Disease Progression; Etanercept; Humans; Male; Middle Aged; Stevens-Johnson Syndrome	2023
[Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2019, Volume: 139, Issue:12 Topics: Acetaminophen; Adrenal Cortex Hormones; Allopurinol; Antigens, Differentiation, T-Lymphocyte; Carbamazepine; CD8-Positive T-Lymphocytes; Cyclosporine; Epidermis; Etanercept; Fas Ligand Protein; HLA Antigens; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Japan; Lamotrigine; Plasma Exchange; Stevens-Johnson Syndrome; Tumor Necrosis Factor-alpha	2019
Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review. Advances in wound care, 2020, Volume: 9, Issue:7 Topics: Adrenal Cortex Hormones; Animals; Bandages; Burn Units; Cyclosporine; Holistic Health; Hospitalization; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Length of Stay; Nutritional Support; Palliative Care; Patient Care Team; Skin; Skin Transplantation; Stevens-Johnson Syndrome; Swine; Tertiary Care Centers; Transplantation, Heterologous; Treatment Outcome; Wound Healing	2020
Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology : JEADV, 2021, Volume: 35, Issue:1 Topics: Adrenal Cortex Hormones; Cyclosporine; Humans; Retrospective Studies; Stevens-Johnson Syndrome	2021
Three toxic epidermal necrolysis cases treated with cyclosporine and a review of the literature. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Cyclosporine; Humans; Stevens-Johnson Syndrome	2020
Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. JAMA dermatology, 2017, 06-01, Volume: 153, Issue:6 Topics: Cyclosporine; Glucocorticoids; Humans; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Randomized Controlled Trials as Topic; Stevens-Johnson Syndrome	2017
Cyclosporine in toxic epidermal necrolysis: a brief review of the emerging therapeutic modality. Dermatology online journal, 2016, Oct-15, Volume: 22, Issue:10 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Stevens-Johnson Syndrome	2016
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. Advances in therapy, 2017, Volume: 34, Issue:6 Topics: Adrenal Cortex Hormones; Combined Modality Therapy; Cyclosporine; Humans; Immunoglobulins, Intravenous; Stevens-Johnson Syndrome; Tumor Necrosis Factor-alpha	2017
Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches. The Journal of investigative dermatology, 2017, Volume: 137, Issue:10 Topics: Cyclosporine; Global Health; Humans; Immunosuppressive Agents; Research Design; Stevens-Johnson Syndrome; Survival Rate	2017
A Review of the Active Treatments for Toxic Epidermal Necrolysis. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2017, Volume: 84, Issue:3 Topics: Acetylcysteine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infliximab; Plasmapheresis; Stevens-Johnson Syndrome; Thalidomide; Tumor Necrosis Factor-alpha	2017
New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis. The Journal of investigative dermatology, 2017, Volume: 137, Issue:10 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Practice Guidelines as Topic; Stevens-Johnson Syndrome	2017
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Clinical reviews in allergy & immunology, 2018, Volume: 54, Issue:1 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Cyclosporine; Humans; Hypersensitivity, Delayed; Immunoglobulins, Intravenous; Skin; Stevens-Johnson Syndrome; Sulfonamides	2018
The use of cyclosporine for Stevens-Johnson syndrome-toxic epidermal necrolysis spectrum at the University of Louisville: A case series and literature review. Dermatology online journal, 2018, 01-01, Volume: 24, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Male; Middle Aged; Retrospective Studies; Stevens-Johnson Syndrome	2018
Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results. Burns : journal of the International Society for Burn Injuries, 2018, Volume: 44, Issue:4 Topics: Adrenal Cortex Hormones; Allopurinol; Anti-Bacterial Agents; Anticonvulsants; Bandages; British Columbia; Comorbidity; Cyclosporine; Dermatologic Agents; Dermatology; Diabetes Mellitus; Dietetics; Disease Management; Female; Gout; Gout Suppressants; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunologic Factors; Intensive Care Units; Length of Stay; Male; Middle Aged; Mouth Mucosa; Neoplasms; Patient Care Team; Retrospective Studies; Seizures; Stevens-Johnson Syndrome; Surgery, Plastic; Torso	2018
Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis. Dermatologic therapy, 2019, Volume: 32, Issue:1 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Risk Factors; Stevens-Johnson Syndrome; Time Factors; Treatment Outcome	2019
FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis. Actas dermo-sifiliograficas, 2019, Volume: 110, Issue:7 Topics: Cyclosporine; Dermatologic Agents; Humans; Meta-Analysis as Topic; Prospective Studies; Retrospective Studies; Stevens-Johnson Syndrome	2019
Toxic epidermal necrolysis. Current drug safety, 2012, Nov-01, Volume: 7, Issue:5 Topics: Acetylcysteine; Adrenal Cortex Hormones; Cyclosporine; Humans; Plasmapheresis; Prognosis; Stevens-Johnson Syndrome; Tumor Necrosis Factor-alpha	2012
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease. Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:5 Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha	2014
Cyclosporine in SJS/TEN management: a brief review. Cutis, 2016, Volume: 97, Issue:3 Topics: Adrenal Cortex Hormones; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Stevens-Johnson Syndrome; Treatment Outcome	2016
Review of Toxic Epidermal Necrolysis. International journal of molecular sciences, 2016, Dec-18, Volume: 17, Issue:12 Topics: Antigens, Differentiation, T-Lymphocyte; Apoptosis; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Epidermis; Fas Ligand Protein; Granulocyte Colony-Stimulating Factor; Granzymes; Humans; Immunoglobulins, Intravenous; Infliximab; Keratinocytes; Mucous Membrane; Perforin; Stevens-Johnson Syndrome; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2016
An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Current opinion in pediatrics, 2009, Volume: 21, Issue:4 Topics: Antibodies, Monoclonal; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Glucocorticoids; Humans; Immunoglobulins; Immunologic Factors; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Plasmapheresis; Skin Care; Stevens-Johnson Syndrome; Treatment Outcome	2009
Cyclosporine for SJS/TEN: a case series and review of the literature. Cutis, 2011, Volume: 87, Issue:1 Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Infective Agents; Anticonvulsants; Cyclosporine; Dermatologic Agents; Drug Combinations; Female; Humans; Lamotrigine; Male; Stevens-Johnson Syndrome; Sulfamethizole; Triazines; Trimethoprim	2011
The management of toxic epidermal necrolysis. The Australasian journal of dermatology, 2012, Volume: 53, Issue:3 Topics: Acetylcysteine; Adrenal Cortex Hormones; Burn Units; Cyclosporine; Enzyme Inhibitors; Free Radical Scavengers; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Pharmacogenetics; Plasmapheresis; Stevens-Johnson Syndrome; Tumor Necrosis Factor Inhibitors	2012
Toxic epidermal necrolysis: current evidence, practical management and future directions. The British journal of dermatology, 2005, Volume: 153, Issue:2 Topics: Adrenal Cortex Hormones; Apoptosis; CD8-Positive T-Lymphocytes; Cyclosporine; Fas Ligand Protein; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Insulin; Membrane Glycoproteins; Models, Biological; Nutritional Physiological Phenomena; Stevens-Johnson Syndrome; Tumor Necrosis Factor-alpha; Zinc	2005
[Toxic epidermal necrolysis (drug-induced Lyell's syndrome). 2. Treatment]. Deutsche medizinische Wochenschrift (1946), 2001, Feb-16, Volume: 126, Issue:7 Topics: Adrenal Cortex Hormones; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Antidotes; Cyclophosphamide; Cyclosporine; Cystine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Pentoxifylline; Plasmapheresis; Stevens-Johnson Syndrome	2001

Trials

3 trial(s) available for cyclosporine and Stevens-Johnson Syndrome

Article	Year
Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. The British journal of dermatology, 2010, Volume: 163, Issue:4 Topics: Adolescent; Adult; Aged; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Middle Aged; Patient Selection; Pilot Projects; Stevens-Johnson Syndrome; Young Adult	2010
Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:3 Topics: Administration, Ophthalmic; Adult; Aged; Aged, 80 and over; Cyclosporine; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Stevens-Johnson Syndrome; Time Factors; Treatment Outcome; Young Adult	2013
Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis. Archives of dermatological research, 2005, Volume: 297, Issue:6 Topics: Adult; Aged; Apoptosis; Cyclosporine; Dermis; fas Receptor; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Stevens-Johnson Syndrome	2005

Other Studies

49 other study(ies) available for cyclosporine and Stevens-Johnson Syndrome

Article	Year
Toxic Epidermal Necrolysis Caused by Allopurinol: A Serious but Still Underestimated Adverse Reaction. The American journal of case reports, 2021, Oct-11, Volume: 22 Topics: Aged; Allopurinol; Blister; Cyclosporine; Exanthema; Female; Humans; Stevens-Johnson Syndrome	2021
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine. Methods in molecular biology (Clifton, N.J.), 2022, Volume: 2486 Topics: Cyclosporine; Humans; Keratinocytes; Skin; Stevens-Johnson Syndrome; Systems Analysis; Tumor Necrosis Factor-alpha	2022
Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. The Journal of dermatology, 2022, Volume: 49, Issue:6 Topics: Cohort Studies; Cyclosporine; Glucocorticoids; Humans; Retrospective Studies; Stevens-Johnson Syndrome	2022
Highlighting adalimumab as a treatment option for systemic treatment of toxic epidermal necrolysis: A case series from a tertiary specialised burns centre. The Australasian journal of dermatology, 2022, Volume: 63, Issue:4 Topics: Adalimumab; Burns; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Retrospective Studies; Stevens-Johnson Syndrome	2022
Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation. Allergy, 2023, Volume: 78, Issue:5 Topics: Cyclosporine; Humans; Immunoglobulins, Intravenous; Proteomics; Retrospective Studies; Skin; Stevens-Johnson Syndrome	2023
[Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2019, Oct-18, Volume: 51, Issue:5 Topics: Adrenal Cortex Hormones; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Middle Aged; Skin; Stevens-Johnson Syndrome	2019
The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease. The ocular surface, 2021, Volume: 19 Topics: Cohort Studies; Corneal Diseases; Cyclosporine; Follow-Up Studies; Humans; Retrospective Studies; Stevens-Johnson Syndrome; Visual Acuity	2021
Stevens-Johnson syndrome and toxic epidermal necrolysis. JAAPA : official journal of the American Academy of Physician Assistants, 2020, Volume: 33, Issue:8 Topics: Crystalloid Solutions; Cyclosporine; Electrolytes; Hospitalization; Humans; Interdisciplinary Communication; Male; Middle Aged; Pain Management; Patient Care Team; Resuscitation; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination	2020
Toxic Epidermal Necrolysis in a Boy: Successful Treatment With Cyclosporine A. Actas dermo-sifiliograficas, 2021, Volume: 112, Issue:5 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Male; Stevens-Johnson Syndrome	2021
Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. The British journal of ophthalmology, 2022, Volume: 106, Issue:8 Topics: Adult; Aged; Cyclosporine; Dry Eye Syndromes; Female; Humans; Male; Middle Aged; Pemphigoid, Benign Mucous Membrane; Retrospective Studies; Stevens-Johnson Syndrome	2022
COVID-19 vaccine-induced Stevens-Johnson syndrome. Clinical and experimental dermatology, 2021, Volume: 46, Issue:8 Topics: Administration, Oral; COVID-19; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Male; Middle Aged; SARS-CoV-2; Skin; Stevens-Johnson Syndrome; Treatment Outcome	2021
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study. JAMA dermatology, 2021, Oct-01, Volume: 157, Issue:10 Topics: Adult; Cohort Studies; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Middle Aged; Retrospective Studies; Stevens-Johnson Syndrome	2021
Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children. Pediatric dermatology, 2017, Volume: 34, Issue:5 Topics: Boston; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Infant; Length of Stay; Male; Skin; Stevens-Johnson Syndrome; Time Factors; Treatment Outcome	2017
Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses. The Journal of investigative dermatology, 2018, Volume: 138, Issue:6 Topics: Acute Kidney Injury; Adult; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Palliative Care; Propensity Score; Re-Epithelialization; Retrospective Studies; Skin; Stevens-Johnson Syndrome; Survival Analysis; Treatment Failure	2018
Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors. The Journal of investigative dermatology, 2018, Volume: 138, Issue:9 Topics: Adult; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Global Health; Humans; Male; Morbidity; Prognosis; Risk Assessment; Stevens-Johnson Syndrome; Survival Rate	2018
Toxic epidermal necrolysis data from the CELESTE multinational registry. Part II: Specific systemic and local risk factors for the development of infectious complications. Burns : journal of the International Society for Burn Injuries, 2018, Volume: 44, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Aged; Bacteremia; Bacterial Infections; Cyclosporine; Czech Republic; Female; Fungemia; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Pneumonia; Registries; Respiration, Artificial; Retrospective Studies; Risk Factors; Severity of Illness Index; Slovakia; Stevens-Johnson Syndrome; Tracheostomy; Urinary Tract Infections	2018
Cyclosporine-induced toxic leukoencephalopathy in toxic epidermal necrolysis. International journal of dermatology, 2019, Volume: 58, Issue:2 Topics: Adult; Amoxicillin; Cyclosporine; Female; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Stevens-Johnson Syndrome; Sulfonamides	2019
Use of cyclosporine for the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis. Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:2 Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Male; Middle Aged; Retrospective Studies; Stevens-Johnson Syndrome; Young Adult	2021
Intravenous cyclosporine in treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis: A case series. Dermatologic therapy, 2019, Volume: 32, Issue:4 Topics: Administration, Intravenous; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Stevens-Johnson Syndrome; Treatment Outcome	2019
Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2014, Volume: 67, Issue:8 Topics: Administration, Topical; Adult; Algorithms; Burn Units; Coated Materials, Biocompatible; Cyclosporine; Emollients; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Severity of Illness Index; Silicones; Skin Diseases, Bacterial; Skin Transplantation; Stevens-Johnson Syndrome; United Kingdom	2014
Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:5 Topics: Adult; Aged; Cyclosporine; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Survival Rate	2014
Toxic epidermal necrolysis induced by vemurafenib. Actas dermo-sifiliograficas, 2015, Volume: 106, Issue:8 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Drug Substitution; Humans; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Neoplasm Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Stevens-Johnson Syndrome; Sulfonamides; Vemurafenib	2015
Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey. Journal of the American Academy of Dermatology, 2016, Volume: 74, Issue:2 Topics: Attitude of Health Personnel; Bandages; Cyclosporine; Debridement; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Internet; Practice Patterns, Physicians'; Steroids; Stevens-Johnson Syndrome; Surveys and Questionnaires	2016
Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation. The Journal of pediatrics, 2016, Volume: 173 Topics: Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Epidermolysis Bullosa Dystrophica; Humans; Immunosuppressive Agents; Male; Mesenchymal Stem Cell Transplantation; Stevens-Johnson Syndrome	2016
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome. Ophthalmology, 2016, Volume: 123, Issue:8 Topics: Acute Disease; Amnion; Anti-Bacterial Agents; Combined Modality Therapy; Cyclosporine; Dexamethasone; Dry Eye Syndromes; Eyelid Diseases; Female; Fluorophotometry; Fluoroquinolones; Glucocorticoids; Guidelines as Topic; Humans; Middle Aged; Moxifloxacin; Prospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Tobramycin; Visual Acuity	2016
U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. The British journal of dermatology, 2016, Volume: 174, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Aftercare; Analgesia; Biological Dressings; Critical Pathways; Cyclosporine; Eye Diseases; Female; Female Urogenital Diseases; Fluid Therapy; Forecasting; Humans; Immunoglobulins, Intravenous; Lymphocyte Activation; Male; Male Urogenital Diseases; Mouth Diseases; Nutritional Support; Prognosis; Respiratory Tract Diseases; Skin Care; Skin Irritancy Tests; Stevens-Johnson Syndrome	2016
Ophthalmic Considerations in Stevens-Johnson Syndrome. The Journal of pediatrics, 2016, Volume: 175 Topics: Adolescent; Anti-Bacterial Agents; Biological Dressings; Conjunctivitis; Cyclosporine; Erythromycin; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Prednisolone; Stevens-Johnson Syndrome	2016
Cyclosporine treatment for Stevens-Johnson syndrome/toxic epidermal necrolysis: Retrospective analysis of a cohort treated in a specialized referral center. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Burn Units; Cyclosporine; Female; Hospital Mortality; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome	2017
Acute Generalized Erythrodermic Pustular Psoriasis Associated with Bupropion/Naltrexone (Contrave The Journal of emergency medicine, 2017, Volume: 52, Issue:4 Topics: Acute Kidney Injury; Biopsy; Bupropion; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Middle Aged; Naltrexone; Psoriasis; Stevens-Johnson Syndrome	2017
Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine. Clinical rheumatology, 2009, Volume: 28, Issue:12 Topics: Aged; Antirheumatic Agents; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Skin Diseases, Vesiculobullous; Stevens-Johnson Syndrome; Treatment Outcome	2009
Prevention of severe cutaneous adverse drug reactions: the emerging value of pharmacogenetic screening. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Mar-23, Volume: 182, Issue:5 Topics: Adult; Alleles; Allopurinol; Anticonvulsants; Asian People; Carbamazepine; China; Cyclosporine; Drug Hypersensitivity; Genetic Predisposition to Disease; Genetic Testing; Gout Suppressants; HLA-B Antigens; Humans; Immunization, Passive; Immunosuppressive Agents; Keratoconjunctivitis; Male; Stevens-Johnson Syndrome; Urethritis	2010
Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye: comment. Clinical & experimental ophthalmology, 2010, Volume: 38, Issue:1 Topics: Acute Disease; Administration, Topical; Adult; Cyclosporine; Dry Eye Syndromes; Female; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Stevens-Johnson Syndrome; Treatment Outcome	2010
Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre. Clinical and experimental dermatology, 2010, Volume: 35, Issue:8 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Burn Units; Cyclophosphamide; Cyclosporine; England; Female; Hospitals, University; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Treatment Outcome; Young Adult	2010
[Toxic epidermal necrolysis treated with cyclosporin A]. Medicina intensiva, 2011, Volume: 35, Issue:7 Topics: Adult; Allopurinol; Amoxicillin-Potassium Clavulanate Combination; Cyclosporine; Female; Humans; Immunologic Factors; Male; Middle Aged; Remission Induction; Stevens-Johnson Syndrome	2011
Proteomic kinetic analysis of blister fluid and serum in a patient with drug-induced toxic epidermal necrolysis. A comparison with skin immunohistochemistry. Current drug safety, 2012, Nov-01, Volume: 7, Issue:5 Topics: Adult; Blister; Cyclosporine; Female; Glutathione S-Transferase pi; Humans; Immunohistochemistry; Lipopolysaccharide Receptors; Macrophage Activation; Peroxidase; Proteomics; Stevens-Johnson Syndrome	2012
Early cyclosporine treatment of incipient toxic epidermal necrolysis induced by concomitant use of lamotrigine and sodium valproate. Acta dermato-venereologica, 2004, Volume: 84, Issue:1 Topics: Adult; Anticonvulsants; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Epilepsy, Complex Partial; Female; Humans; Lamotrigine; Stevens-Johnson Syndrome; Triazines; Valproic Acid	2004
Stevens-Johnson syndrome induced by mizoribine in a patient with systemic lupus erythematosus. Modern rheumatology, 2006, Volume: 16, Issue:2 Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Lupus Nephritis; Prednisolone; Ribonucleosides; Stevens-Johnson Syndrome; Treatment Outcome	2006
[Odinophagia and cutaneous lesions in patient with cerebral metastases]. Revista clinica espanola, 2006, Volume: 206, Issue:5 Topics: Aged; Anticonvulsants; Back; Brain Neoplasms; Cyclosporine; Dermis; Epilepsy; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Mouth Mucosa; Necrosis; Phenytoin; Skin Diseases; Stevens-Johnson Syndrome	2006
Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone. Pediatrics international : official journal of the Japan Pediatric Society, 2007, Volume: 49, Issue:5 Topics: Child; Cyclosporine; Drug Therapy, Combination; Female; Humans; Methylprednisolone; Stevens-Johnson Syndrome; Treatment Outcome	2007
[Ocular surface disease due to Stevens-Johnson syndrome treated with oral cyclosporin]. Anales de pediatria (Barcelona, Spain : 2003), 2008, Volume: 68, Issue:1 Topics: Administration, Oral; Corneal Ulcer; Cyclosporine; Humans; Infant, Newborn; Keratitis; Male; Stevens-Johnson Syndrome	2008
Toxic epidermal necrolysis associated with severe hypocalcaemia, and treated with cyclosporin. The British journal of dermatology, 1995, Volume: 133, Issue:2 Topics: Adult; Cyclosporine; Female; Humans; Hypocalcemia; Immunosuppressive Agents; Stevens-Johnson Syndrome	1995
Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factor. Clinical and experimental dermatology, 1997, Volume: 22, Issue:3 Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Cyclosporine; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Neutropenia; Recombinant Proteins; Stevens-Johnson Syndrome	1997
[Toxic epidermal necrolysis. Therapeutic trends]. Anales de medicina interna (Madrid, Spain : 1984), 1998, Volume: 15, Issue:7 Topics: Adrenal Cortex Hormones; Cyclophosphamide; Cyclosporine; Enteral Nutrition; Fluid Therapy; Humans; Immunosuppressive Agents; Stevens-Johnson Syndrome; Time Factors	1998
Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis? Dermatology (Basel, Switzerland), 1999, Volume: 198, Issue:2 Topics: Apoptosis; Cyclosporine; Humans; Keratinocytes; Macrophages; Stevens-Johnson Syndrome; T-Lymphocytes; Tumor Necrosis Factor-alpha	1999
Toxic epidermal necrolysis in a patient with psoriatic arthritis. Advances in experimental medicine and biology, 1999, Volume: 455 Topics: Adrenal Cortex Hormones; Arthritis, Psoriatic; Cyclosporine; Erythema; Female; Humans; Immunosuppressive Agents; Middle Aged; Plasmapheresis; Stevens-Johnson Syndrome	1999
Treatment of toxic epidermal necrolysis with cyclosporin A. The Journal of trauma, 2000, Volume: 48, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Burns; Critical Care; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Stevens-Johnson Syndrome; Treatment Outcome	2000
Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF. Journal of medicine, 2001, Volume: 32, Issue:1-2 Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anemia, Aplastic; Cyclosporine; Granulocyte Colony-Stimulating Factor; Humans; Male; Penicillin V; Penicillins; Severity of Illness Index; Stevens-Johnson Syndrome	2001
[Blistering cutaneous lesions in a patient with systemic lupus erythematosis]. Revista clinica espanola, 2001, Volume: 201, Issue:5 Topics: Adult; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Stevens-Johnson Syndrome	2001
Toxic epidermal necrolysis treated with cyclosporin. Clinical and experimental dermatology, 1992, Volume: 17, Issue:4 Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Humans; Liver; Prednisolone; Stevens-Johnson Syndrome	1992